Answer:D) noise.
Explanation:
Noise is unwanted sound that usually comes in an unpleasant way that tends to be loud , which usually disrupt our focus and our own conversation and our ability to hear others around us.
It usually can't be interpreted by our brain because it comes all at once with different sounds all combined together.
When people keep talking over you whilst you are talking to someone else it becomes hard to focus on your message with their voices over you , this is what happening to Ivan.
Whilst he is trying to process and encode his message to the customer the voices of his colleagues are disruptive to this.
Hello There!
<span>John and Monique are married. Both of their parents live with them, as does john's sister and brother-in-law and some nieces and nephews. This is known as a kinship network.</span>
Hope This Helps You!
Good Luck :)
- Hannah ❤
<span>Cognitive-behavioral therapy (CBT)
This therapy was designed to be</span><span> a short-term, goal-oriented </span>psychotherapy<span> treatment that takes a hands-on, practical approach to problem-solving. Its goal is to change the thinkings or behavior that are behind people’s problems and change the way they see life. It helps in descovering behavioral change and less depression and anxiety</span>
Examples of how the environment can influence the expression of a gene is for example, pigmentation. Temperature can ultimately effect the pigmentation of a person. Those who are closer to the equator appear more dark, naturally because the temperatures are hotter.
AXS-05-MDD-301: a randomized, double-blind, placebo-controlled trial of AXS-05 in subjects with major glutamatergic neurotransmission disorder.
Altered glutamatergic neurotransmission has been implicated in the pathogenesis of depression. This trial evaluated the efficacy and protection of AXS-05 (dextromethorphan-bupropion), an oral N-methyl-D-aspartate receptor antagonist and σ1 receptor agonist, inside the remedy for the most important depressive disorder.
This double-blind, segment three trial, turned into conducted between patients with a DSM-five prognosis of MDD had been randomized in a 1:1 ratio to acquire dextromethorphan-bupropion (45 mg-105 mg pill) or placebo, orally (once each day for days 1-3, two times every day thereafter) for 6 weeks. The primary endpoint became the exchange from baseline to week 6 within the 1st viscount Montgomery of Alamein-Asberg depression rating Scale total score. different efficacy endpoints and variables covered changes from baseline at weeks 1 and 2, scientific remission.
Learn more about depressive disorder here:-brainly.com/question/12743811
#SPJ4